Discover the complete record of transactions filed by Drutz David, Director. Officer active across 1 companies, notably Altimmune, Inc.. In total, 8 reports have been recorded. Total volume traded: €13k. The latest transaction was filed on 15 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
David Drutz is a Board Member at Altimmune, Inc. He participates in overseeing the company's activities and making strategic decisions. His experience in the biopharmaceutical field allows him to provide valuable insights to the leadership.